Successes Highlighted in New Report

CDC uses One Health approach to combat AR 

CDC Highlights Collaborative Antimicrobial Resistance Success Stories

CDC leads the United States (U.S.) public health response to combat antimicrobial resistance (AR) by investing in domestic and global programs. Recently, CDC highlighted some AR success stories across One Health–recognizing the health of people is connected to the health of animals and the environment.  Successes in 2022 include:  The Global Antimicrobial Resistance Laboratory and Response Network continued to grow, spanning nearly 50 countries and working with more than 20 organizations worldwide. The broad-reaching, One Health network works to build laboratory capacity to detect antimicrobial-resistant organisms, prevent infections in health care and the community through proven infection prevention and control practices, and apply innovative ways to respond to AR threats.  The National Healthcare Safety Network (NHSN) reached a milestone by enrolling more than 38,000 U.S. healthcare facilities. NHSN is a tracking and response system that identifies emerging and enduring threats, including antimicrobial-resistant infections, across healthcare facilities. Data can be used to rapidly identify unusual increases in antimicrobial-resistant infections, improve patient safety, and save lives.  The National Wastewater Surveillance System (NWSS) provides useful data that could signal an early warning of emerging infectious disease threats, including antimicrobial-resistant organisms. CDC and public health partners are exploring ways to use NWSS to better respond to other threats detectable in wastewater, such as antimicrobial-resistant pathogens, foodborne pathogens like Escherichia coli, respiratory viruses like influenza, and emerging pathogens like Candida auris. Expanding NWSS capabilities, participation, and strengthened relationships with wastewater partners will help prepare communities to detect and track disease threats now and in years to come.

Read more about these collective efforts and others that reflect CDC’s commitment to protect people from infectious disease threats, including those that are resistant to antibiotics or antifungals, when and where they emerge.

Receive this from a friend? Sign up by entering your email address here.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

Strengthening AR Detection & Reporting in Brazil

CDC helps hospitals & labs rapidly detect & respond to critical AR threats

In Brazil, CDC and Partners Show Early Successes in Improving AR Surveillance Increased lab capacity is driving better detection and enhancing patient care

CDC’s investments in domestic and global partnerships are critical to help combat antimicrobial resistance (AR). As part of CDC’s Global Antimicrobial Resistance Laboratory & Response Network, the Oswaldo Cruz Foundation (FIOCRUZ), through the Foundation for Scientific Technological Development in Health (FIOTEC), is supporting Brazil’s National Public Health Laboratory Network to strengthen AR detection and reporting in Brazil.  The collaboration has enabled laboratories to get needed supplies to detect AR genes, implement standardized procedures for lab testing, and train staff. The resulting improvements in AR detection and reporting can help clinicians make better treatment choices for patients and guide antimicrobial-resistant infection prevention and response activities—all of which protect patient safety.

Building upon the success of the first year of collaboration, CDC is supporting FIOTEC to expand the project across all five regions in Brazil. Read more about how laboratories in Brazil, with partner support, built capacity for AR data collection.

	CDC & partners are helping labs in Brazil better detect & rapidly report critical #AntimicrobialResistance threats through CDC’s Global AR Lab & Response Network. Read the full story for more on this successful partnership: https://bit.ly/43jdDOS

Receive this from a friend? Sign up by entering your email address here.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

New blog: Vietnam hospital combats AR

A CDC-supported initiative in Vietnam shows the positive impact IPC activities can have on CRE prevention

Implementing Infection Prevention and Control Measures Reduces CRE in Vietnam

Carbapenem-resistant Enterobacterales (CRE) are identified as an urgent antimicrobial resistance (AR) threat in CDC’s 2019 AR Threats Report. CRE can spread quickly in healthcare settings and cause severe, difficult-to-treat infections. Infection prevention and control (IPC) is critical to prevent the spread of these bacteria.  The latest Safe Healthcare Blog highlights a CDC-supported initiative at a hospital in Vietnam that has used IPC quality improvement strategies to reduce CRE colonization and infection in an intensive care unit. Visit the blog to learn more about how IPC activities successfully reduced CRE in this hospital where it was initially very high and about how this success is informing global work to detect, prevent, and respond to AR through CDC’s Global Action in Healthcare Network.

A hospital staff member in Vietnam demonstrates personal protective equipment and a new area for caring for patients with CRE.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe